| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |